Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding Reagents

Patent No. EP2956483 (titled "Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding Reagents") was filed by Boehringer Ingelheim on Feb 12, 2014. The application was issued on May 27, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2956483

BOEHRINGER INGELHEIM
Application Number
EP14705561A
Filing Date
Feb 12, 2014
Status
Revoked
Sep 9, 2022
Publication Date
May 27, 2020